EU Approves Novartis Corporation Buy Of Vaccine Maker Chiron Corporation

February 6, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

BRUSSELS, Feb 6 (Reuters) - Swiss drug maker Novartis (NOVN.VX: Quote, Profile, Research) won approval on Monday from Europe's competition authorities to acquire vaccine maker Chiron (CHIR.O: Quote, Profile, Research).

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions Europe